Two Sigma Investments’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Two Sigma Investments’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21,001	Closed	-$112K	–	4143
2019 Q3	$112K	Sell	21,001 -8,216	-28%	-$54.7K	﹤0.01%	3294
2019 Q2	$281K	Sell	29,217 -8,241	-22%	-$152K	﹤0.01%	2900
2019 Q1	$1M	Sell	37,458 -1,840	-5%	-$46.8K	﹤0.01%	1825
2018 Q4	$888K	Buy	39,298 +13,798	+54%	+$540K	﹤0.01%	1726
2018 Q3	$1.41M	Buy	+25,500	New	+$1.63M	﹤0.01%	1730
2018 Q1	–	Sell	-3,221	Closed	-$406K	–	3696
2017 Q4	$406K	Buy	3,221 +2,366	+277%	+$303K	﹤0.01%	2571
2017 Q3	$117K	Buy	+855	New	+$114K	﹤0.01%	2640
2017 Q2	–	Sell	-4,716	Closed	-$867K	–	3420
2017 Q1	$867K	Buy	4,716 +4,138	+716%	+$464K	﹤0.01%	2008
2016 Q4	$47K	Buy	+578	New	+$45.7K	﹤0.01%	3012
2016 Q2	–	Sell	-7,659	Closed	-$709K	–	3384
2016 Q1	$709K	Buy	+7,659	New	+$765K	﹤0.01%	1819
2015 Q3	–	Sell	-3,335	Closed	-$3.16M	–	2930
2015 Q2	$3.16M	Sell	3,335 -549	-14%	-$449K	0.01%	940
2015 Q1	$2.85M	Buy	+3,884	New	+$2.92M	0.01%	977

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Investments's TTPH Position: Q4 2019 in Review

Two Sigma Investments sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2019, closing a stake of 21,001 shares — an estimated $112K sold.

Two Sigma Investments first reported a position in TTPH in Q1 2015 and held it in 12 quarters. The position peaked at $3.16M in Q2 2015. 23 funds tracked by Wall St. Rank hold TTPH as of Q4 2019.

Two Sigma Investments reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Two Sigma Investments sold 21,001 Tetraphase Pharmaceuticals, Inc. shares in Q4 2019, an estimated $112K.
Two Sigma Investments first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 12 quarters.
Two Sigma Investments's Tetraphase Pharmaceuticals, Inc. position peaked at $3.16M in Q2 2015.
23 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.